294
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

A potential new role of ATM inhibitor in radiotherapy: suppressing ionizing Radiation-Activated EGFR

, , , &
Pages 461-468 | Received 08 Sep 2019, Accepted 14 Dec 2019, Published online: 08 Jan 2020

References

  • Bensimon A, Aebersold R, Shiloh Y. 2011. Beyond ATM: The protein kinase landscape of the DNA damage response. FEBS Lett. 585(11):1625–1639.
  • Blasco M. T, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga C. G, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, et al. 2019. Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF. Cancer Cell. 35(4):573–587.e576.
  • Carruthers R, Ahmed S U, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers A J. 2015. Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase. Mol Oncol. 9(1):192–203.
  • Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC. 2009. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys. 75(5): 01.
  • Chen D. J, Nirodi C. S. 2007. The epidermal growth factor receptor: a role in repair of Radiation-Induced DNA damage. Clin Cancer Res. 13(22):6555–6560.
  • Dittmann K, Mayer C, Rodemann H. P. 2005. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol. 76(2):157–161.
  • Durant ST, Zheng L, Wang Y, Chen K, Zhang L, Zhang T, Yang Z, Riches L, Trinidad AG, Fok JHL, et al. 2018. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv. 4(6):06.
  • Erdem-Eraslan L, Gao Y, Kloosterhof N. K, Atlasi Y, Demmers J, Sacchetti A, Kros J. M, Sillevis Smitt P, Aerts J, et al. 2015. Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. Eur J Cancer. 51(7):893–903.
  • Fan Q.-W, Cheng C. K, Gustafson W. C, Charron E, Zipper P, Wong R. A, Chen J, Lau J, Knobbe-Thomsen C, Weller M, et al. 2013. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell. 24(4):438–449.
  • Friedmann B. J, Caplin M, Savic B, Shah T, Lord C. J, Ashworth A, Hartley J. A, Hochhauser D. 2006. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol Cancer Ther. 5(2):209–218.
  • Golding S. E, Rosenberg E, Khalil A, McEwen A, Holmes M, Neill S, Povirk L. F, Valerie K. 2004. Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J Biol Chem. 279(15):15402–15410.
  • Graham R. P, Treece A. L, Lindeman N. I, Vasalos P, Shan M, Jennings L. J, Rimm D. L. 2018. Worldwide frequency of commonly detected EGFR mutations. Arch Pathol Lab Med. 142(2):163–167.
  • Gunn A, Bennardo N, Cheng A, Stark J. M. 2011. Correct end use during end joining of multiple chromosomal double strand breaks is influenced by repair protein RAD50, DNAdependent protein kinase DNA-PKcs, and transcription context. J Biol Chem. 286(49):42470–42482.
  • Herbst R. S. 2004. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 59(2 Suppl):21–26.
  • Hu B, Wang X, Hu S, Ying X, Wang P, Zhang X, Wang J, Wang H, Wang Y. 2017. miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks. J Biol Chem. 292(8):3531–3540.
  • Kang K. B, Zhu C, Wong Y. L, Gao Q, Ty A, Wong M. C. 2012. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNAPK signaling, accompanied by inhibition of DNA double-strand break repair. Int J Radiat Oncol Biol Phys. 83(1):e43–52.
  • Lee H. J, Lan L, Peng G, Chang W. C, Hsu M. C, Wang Y. N, Cheng C. C, Wei L, Nakajima S, Chang S. S, et al. 2015. Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response. Cell Res. 25(2):225–236.
  • Liccardi G, Hartley J. A, Hochhauser D. 2014. Importance of EGFR/ERCC1 interaction following radiation-induced DNA damage. Clin Cancer Res. 20(13):3496–3506.
  • Lucero H, Gae D, Taccioli G. E. 2003. Novel localization of the DNA-PK complex in lipid rafts: a putative role in the signal transduction pathway of the ionizing radiation response. J Biol Chem. 278(24):22136–22143.
  • Moore M. J, Goldstein D, Hamm J, Figer A, Hecht J. R, Gallinger S, Au H. J, Murawa P, Walde D, Wolff R. A, et al. 2007. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 25(15):1960–1966.
  • Shen M, Xu Z, Xu W, Jiang K, Zhang F, Ding Q, Xu Z, Chen Y. 2019. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. J Exp Clin Cancer Res. 38(1):8.
  • Singh D, Attri B. K, Gill R. K, Bariwal J. 2016. Review on EGFR inhibitors: critical updates. Mini Rev Med Chem. 16(14):1134–1166.
  • Stockert J. C, Horobin R. W, Colombo L. L, Blazquez-Castro A. 2018. Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectives. Acta Histochem. 120(3):159–167.
  • Tang S, Liu L, Liu M, Li Z, Liu J, Wang H, Wang J, Oh Y.-T, Shen L, Wang Y. 2019. Ionizing radiation-induced growth in soft agar is associated with miR-21 upregulation in wild-type and DNA double strand break repair deficient cells. DNA Repair. 78:37–44.
  • Verma P, Greenberg R. A. 2016. Noncanonical views of homology-directed DNA repair. Genes Dev. 30(10):1138–1154.
  • Wee P, Wang Z. 2017. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 9(5):52.
  • Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, et al. 2019. N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway. Mol Cancer. 18(1):11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.